Skip to content

Integrated Traditional Chinese and Western Medicine Treatment for Pelvic Floor Dysfunciton:A clinical randomized controlled trial of electroacupuncture combined with behavioral therapy for the treatment of overactive bladder

Integrated Traditional Chinese and Western Medicine Treatment for Pelvic Floor Dysfunciton:A clinical randomized controlled trial of electroacupuncture combined with behavioral therapy for the treatment of overactive bladder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500115683
Enrollment
Unknown
Registered
2025-12-30
Start date
2025-02-23
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive bladder

Interventions

Part 1, Control group:None
Part 1, Newly diagnosed group:None
Part 1, Post-treatment group:None
Part 2, Experimental group:Electroacupuncture+Behavial training
Part 2, Control group:Fake electroacupuncture+Behavial training

Sponsors

Shanghai Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Female, aged between 18 and 75 years old; 2.Meeting the diagnostic criteria for overactive bladder (OAB); 3. Understanding and agreeing to participate in this study and signing the informed consent form; 4. 3 points = OAB Symptom Score (OABSS) <= 11 points; 5. Never have received acupuncture treatment.

Exclusion criteria

Exclusion criteria: 1.Patients with various acute urinary tract infections; 2.Pregnant and lactating women and patients with mental disorders; 3.Patients with obvious organic lesions (such as bladder, urethra, gynecological, anal, and neurological diseases); 4. Patients with allergic constitutions, epilepsy, bleeding tendencies, infectious skin diseases, or those with contraindications for acupuncture such as having a pacemaker implanted; 5.Patients with severe diseases of the heart, brain, liver, kidneys, and hematopoietic system; 6. Patients who cannot undergo magnetic resonance imaging (MRI) examinations.

Design outcomes

Primary

MeasureTime frame
Overactive Bladder Syndrome Score;

Secondary

MeasureTime frame
Quality of Life score;Pelvic floor muscular tension;Psychological state assessment;Pelvic floor Type II muscle strength;

Countries

China

Contacts

Public ContactYangyun Wang

Shanghai Fifth People's Hospital

wangyangyun1986@163.com+86 186 2176 6816

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026